Biologics Treatment Center for Alzheimer’s Disease 

The Memory Care Biologics Treatment Center is designated as a Center of Excellence by the Alzheimer’s Quality Initiative. We prescribe and provide advanced treatment options for eligible patients, including anti-amyloid therapies such as lecanemab and donanemab.

To begin biologics treatment, a confirmed diagnosis of Alzheimer’s disease with biomarker verification is required. If you need to have Alzheimer’s Disease verification, you will first need to see one of our Memory Care Specialists for a comprehensive evaluation.

If you already have done a work-up for Alzheimer's Disease with Biomarker Verification such as:

• Amyloid PET scan
• Cerebrospinal fluid (CSF) analysis
• P-Tau 217 testing

You may be fast-tracked to one of our anti-amyloid therapy specialists. During this visit, we will review: 

• Treatment eligibility

• Risks and potential benefits

• Monitoring requirements

• The individualized treatment process